Ectosense

ectosense.com

Ectosense is a funded Health-Tech startup on a mission to restore the sleep of the one billion people that suffer from a sleep disorder. We leverage the best techniques in micro-electronics, biomedical signal processing and data science to bring products that are vastly more elegant and effective.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

ASAHI KASEI PHARMA TO SPONSOR RESEARCH FOR DRUG DISCOVERY RESEARCH AND TECHNOLOGY: OPEN INNOVATION 2023

Asahi Kasei | October 17, 2022

news image

Asahi Kasei Pharma, subsidiary of diversified Japanese multinational company Asahi Kasei, is publicly calling for new proposals for drug development research as part of its efforts for open innovation to promote pharmaceutical research and development through enhanced cooperation with universities, research institutes and enterprises around the world. The application period begins at 5:00 a.m. GMT on January 5, 2023 and ends at 8:00 a.m. GMT on February 28, 2023. Asahi Kasei Pharm...

Read More

Pharmacy Market

ALPHA COGNITION ANNOUNCES POSITIVE NEUROPROTECTION DATA FROM PRE-CLINICAL STUDY OF ALPHA-1062 FOR TRAUMATIC BRAIN INJURY

Alpha Cognition Inc. | February 23, 2022

news image

Alpha Cognition Inc. a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce histology data from their intranasal ALPHA-1062 Traumatic Brain Injury (TBI) program. ALPHA-1062 treatment was neuroprotective, preserving hippocampal structure, reducing cell loss and promoting neurogenesis compared to no treatment. Functional recovery data released in December demonstra...

Read More

Business Insights

INDEGENE PARTNERS WITH AMWELL TO EMPOWER LIFE SCIENCES ORGANIZATIONS WITH UNPARALLELED PATIENT SUPPORT SOLUTIONS

Indegene Inc | June 29, 2022

news image

Indegene, a technology-led healthcare solutions provider, announced a partnership with Amwell®, a digital care delivery leader. This collaboration will facilitate life sciences organizations to connect patients to better quality care and drive better health outcomes. Digital patient engagement has disrupted the healthcare landscape. Patients are increasingly becoming more knowledgeable and involved in their health journeys. They want personalized support solutions that are ava...

Read More

Business Insights

THE DANISH NATIONAL GENOME CENTER PARTNERS WITH LIFEBIT TO DELIVER NATIONWIDE PERSONALISED MEDICINE

Lifebit Biotech | April 29, 2022

news image

Lifebit, whose leading technology enables secure analysis over sensitive datasets for researchers and interconnects such large patient cohorts worldwide, today announces a long-term partnership with the Danish National Genome Center (NGC). Lifebit will deploy Lifebit CloudOS to create a Federated Trusted Research Environment within the Danish NGC's supercomputing cluster to serve as the scalable and secure data management and analysis platform for Denmark's national researchers, clinical...

Read More
news image

Pharma Tech

ASAHI KASEI PHARMA TO SPONSOR RESEARCH FOR DRUG DISCOVERY RESEARCH AND TECHNOLOGY: OPEN INNOVATION 2023

Asahi Kasei | October 17, 2022

Asahi Kasei Pharma, subsidiary of diversified Japanese multinational company Asahi Kasei, is publicly calling for new proposals for drug development research as part of its efforts for open innovation to promote pharmaceutical research and development through enhanced cooperation with universities, research institutes and enterprises around the world. The application period begins at 5:00 a.m. GMT on January 5, 2023 and ends at 8:00 a.m. GMT on February 28, 2023. Asahi Kasei Pharm...

Read More
news image

Pharmacy Market

ALPHA COGNITION ANNOUNCES POSITIVE NEUROPROTECTION DATA FROM PRE-CLINICAL STUDY OF ALPHA-1062 FOR TRAUMATIC BRAIN INJURY

Alpha Cognition Inc. | February 23, 2022

Alpha Cognition Inc. a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce histology data from their intranasal ALPHA-1062 Traumatic Brain Injury (TBI) program. ALPHA-1062 treatment was neuroprotective, preserving hippocampal structure, reducing cell loss and promoting neurogenesis compared to no treatment. Functional recovery data released in December demonstra...

Read More
news image

Business Insights

INDEGENE PARTNERS WITH AMWELL TO EMPOWER LIFE SCIENCES ORGANIZATIONS WITH UNPARALLELED PATIENT SUPPORT SOLUTIONS

Indegene Inc | June 29, 2022

Indegene, a technology-led healthcare solutions provider, announced a partnership with Amwell®, a digital care delivery leader. This collaboration will facilitate life sciences organizations to connect patients to better quality care and drive better health outcomes. Digital patient engagement has disrupted the healthcare landscape. Patients are increasingly becoming more knowledgeable and involved in their health journeys. They want personalized support solutions that are ava...

Read More
news image

Business Insights

THE DANISH NATIONAL GENOME CENTER PARTNERS WITH LIFEBIT TO DELIVER NATIONWIDE PERSONALISED MEDICINE

Lifebit Biotech | April 29, 2022

Lifebit, whose leading technology enables secure analysis over sensitive datasets for researchers and interconnects such large patient cohorts worldwide, today announces a long-term partnership with the Danish National Genome Center (NGC). Lifebit will deploy Lifebit CloudOS to create a Federated Trusted Research Environment within the Danish NGC's supercomputing cluster to serve as the scalable and secure data management and analysis platform for Denmark's national researchers, clinical...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us